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mTORC1-dependent translation of collapsin response
mediator protein-2 drives neuroadaptations underlying
excessive alcohol-drinking behaviors
F Liu1, S Laguesse, R Legastelois2, N Morisot, S Ben Hamida3 and D Ron
Mammalian target of rapamycin complex 1 (mTORC1) has an essential role in dendritic mRNA translation and participates in
mechanisms underlying alcohol-drinking and reconsolidation of alcohol-related memories. Here, we report that excessive alcohol
consumption increases the translation of downstream targets of mTORC1, including collapsin response mediator protein-2
(CRMP-2), in the nucleus accumbens (NAc) of rodents. We show that alcohol-mediated induction of CRMP-2 translation is mTORC1-
dependent, leading to increased CRMP-2 protein levels. Furthermore, we demonstrate that alcohol intake also blocks glycogen
synthase kinase-3β (GSK-3β)-phosphorylation of CRMP-2, which results in elevated binding of CRMP-2 to microtubules and a
concomitant increase in microtubule content. Finally, we show that systemic administration of the CRMP-2 inhibitor lacosamide, or
knockdown of CRMP-2 in the NAc decreases excessive alcohol intake. These results suggest that CRMP-2 in the NAc is a convergent
point that receives inputs from two signaling pathways, mTORC1 and GSK-3β, that in turn drives excessive alcohol-drinking
behaviors.
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INTRODUCTION
Addiction is a chronically relapsing disorder, which pathologically
usurps mechanisms underlying learning and memory.1,2 Long-
lasting synaptic plasticity, which underlies the formation of long-
term memories, requires new protein synthesis at dendrites.3
Mammalian target of rapamycin complex 1 (mTORC1) is a
complex containing the serine/threonine protein kinase mTOR,
and the adaptor protein regulatory-associated protein of mTOR
(RAPTOR),4 which plays an important role in initiating the local
translation of synaptic proteins.5,6 Specifically, activation of
mTORC1 leads to the phosphorylation of its two main down-
stream effectors, eukaryotic translation initiation factor 4E binding
protein (4E-BP) and ribosomal protein S6 kinase (S6K).7,8
Phosphorylation of 4E-BP reduces its binding with the eukaryotic
translation initiation factor 4E (eIF4E), leading to the disinhibition
of eIF4E; together with the phosphorylation-dependent S6K
activation, dissociation of eIF4E from phosphorylated 4E-BP
enables the formation of eukaryotic initiation factor complex,
which promotes cap-dependent mRNA translation.9,10
Recently, mTORC1 has been shown to contribute to neuroa-
daptations of several drugs of abuse, including alcohol.11
Specifically for alcohol, we found that excessive alcohol intake
leads to the activation of mTORC1 in the nucleus accumbens
(NAc) of rodents, and that systemic administration or intra-NAc
infusion of the mTORC1 inhibitor, rapamycin,12 reduces excessive
alcohol drinking and seeking.13 We further showed that mTORC1
participates in the maintenance of alcohol-related memories.14
As mTORC1 has an essential role in learning and memory
via the translation of mRNAs at dendrites,5,6 and as psychoactive
drugs including alcohol pathologically utilize normal mechanisms
underlying learning and memory to cause addiction,2 we
hypothesized that mTORC1 mediates neuroadaptations under-
lying alcohol-drinking behaviors by promoting the translation of
synaptic proteins. To test the hypothesis, we selected eight
candidate mRNAs whose translation has been reported to be
controlled by mTORC1,15–19 and whose gene products contribute
to plasticity, learning and memory in the adult brain. Specifically,
we focused our studies on: Arc,20 Ca2+/calmodulin-dependent
protein kinase II (CaMKII),21 the GluA1 subunit of AMPA receptor
(GluA1),22 the GluN1 subunit of NMDA receptor (GluN1),23
Homer,24 postsynaptic density protein-95 (PSD-95),25 RACK126
and collapsin response mediator protein-2 (CRMP-2).27 Using a rat
model of excessive alcohol drinking, we measured the translation
of these mRNAs in the NAc, a central component of the reward
circuit that is critically involved in the etiology of addiction.2 We
show that a history of excessive alcohol drinking leads to the
initiation of the translation of several synaptic proteins, including
CRMP-2. We further show that CRMP-2 in the NAc has a central
role in microtubules assembly in response to alcohol exposure and
to the development and persistence of neuroadaptations under-
lying excessive alcohol-drinking behaviors.
MATERIALS AND METHODS
Further details regarding reagents and procedures can be found in the
Supplementary Information section.
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Animals
Male Long-Evans rats (8–9 week old) were obtained from Harlan
(Indianapolis, IN, USA). Rats were individually housed and kept in a
temperature- and humidity-controlled environment under a 12-hour light/
dark cycle (lights on at 07:00 AM) with free access to food and tap water.
Male C57BL/6J mice (8–9 week old) were obtained from the Jackson
Laboratory (Farmington, CT, USA) and were housed in a temperature- and
humidity-controlled room under a reversed 12 h light/dark cycle (lights on
at 1000 hrs), with food and water available ad libitum. All animal
procedures in this report were approved by the Gallo Center and the
University of California San Francisco (UCSF) Institutional Animal Care and
Use Committee and were conducted in agreement with the Guide for the
Care and Use of Laboratory Animals (National Research Council, Gallo
Center) and the Association for Assessment and Accreditation of
Laboratory Animal Care (UCSF).
Preparation of solutions
Alcohol solution was prepared from ethyl alcohol solution (190 proof)
diluted to 10% or 20% (v/v) in tap water. Rapamycin (10 mg kg− 1 for rats
and 20 mg kg− 1 for mice)13 was dissolved in dimethyl sulfoxide and
systemically (intraperitoneally) administered in a volume of 2 ml kg− 1 for
both rats and mice. Lacosamide (20 mg kg− 1 for rats and 20 or 50 mg kg− 1
for mice)28 was dissolved in saline solution (0.9%), and administered
intraperitoneally in a volume of 2 ml kg− 1 for rats and 10 ml kg− 1 for mice.
Polysomal fractionation
Collection of the NAc was conducted as described previously.29 Polysome-
bound RNA was purified from rat NAc according to a protocol described
previously.30 Fresh rat NAc was snap-frozen in a 1.5 ml Eppendorf tube and
pulverized in liquid nitrogen with a pestle. After keeping on dry ice for
5 min, the powder of one NAc was resuspended in 1 ml lysis buffer (10 mM
Tris pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1% NP40, 0.5% sodium deoxycholate,
40 mM dithiothreitol, 400 U ml− 1 Rnasin, 10 mM RVC and 200 μg ml− 1
cycloheximide) followed by 20 times of pipetting to disrupt cells. In total,
200 μl of the homogenate was subjected to total RNA extraction using
TRIzol reagent. The rest of the homogenate was centrifuged for 10 s at
12 000 g to remove intact nuclei. The supernatant was collected and the
ribosomes were further released by adding 2 extraction buffer (200 mM Tris
pH 7.5, 300 mM NaCl and 200 μg ml− 1 cycloheximide). Samples were kept
on ice for 5 min and then centrifuged at 12 000 g, 4 °C for 5 min to remove
mitochondria and membranous debris. The resulting supernatant was
loaded onto a 15–45% sucrose gradient and centrifuged in a SW41Ti rotor
(Beckman Coulter, Brea, CA, USA) at 38 000 rpm, 4 °C for 2 h. Fractions from
the sucrose gradient were collected and further digested with a solution
containing (400 μg ml− 1 proteinase K, 10 mM ethylenediaminetetraacetic
acid, 1% sodium dodecyl sulfate) at 37 °C for 30 min, followed by phenol–
chloroform extraction. RNA in the water phase of the polysomal fraction
was recovered by ethyl alcohol precipitation.
Reverse transcription-PCR
mRNA levels were measured by reverse transcription-PCR or quantitative
PCR as previously described.31 Primer sequences are specified in the
Supplementary Information section.
Crude synaptosomal fraction and western blot analysis
Purification of the synaptosomal fraction and western blot analysis are
described in.32 Detailed procedures are also described in Supplementary
Information.
Microtubule-binding assay and microtubule content assay
Microtubules-related assays were conducted by using microtubule-binding
protein spin-down assay biochem kit or microtubules/tubulin in vivo
assay biochem kit from Cytoskeleton (Denver, CO, USA), according
to manufacturer’s instructions. Detailed procedures are described in
Supplementary Information.
Generation and usage of a lentivirus expressing shCRMP-2
The 19 nucleotides short hairpin RNA sequence 5’-GUAAACUCCUUCCUC
GUGU-3’ targeting CRMP-2 (Ltv-shCRMP-2) was chosen according to a
published sequence.33 Synthesized DNA oligos containing the above
sequence as well as stem loop were annealed and inserted into pLL3.7
vector at HpaI and XhoI sites. The non-related 19 nucleotides sequence
5’-GCGCUUAGCUGUAGGAUUC-3’ (Ltv-shCT) was used as control. The
production of lentivirus is described in.34 Intra-NAc infusion of lentivirus
(2 × 107 pg ml− 1) was conducted as described in.29
Immunohistochemistry
Immunohistochemistry protocol is described in.29 Detailed procedures are
also described in Supplementary Information.
Behavioral experiments
Alcohol-drinking paradigms. Continuous access to 10% and intermittent
access to 20% alcohol two-bottle choice (CA10%-2BC, IA20%-2BC) drinking
procedures were conducted as previously described in rats35 and mice.36
Effect of lacosamide on alcohol-drinking, voluntary sucrose consumption,
locomotion and anxiety-like behavior. Experiments were conducted by
using a counterbalanced within-subject design using protocols described
previously.29,37
Behavioral experiments following lentiviral infusion. Three weeks after viral
infusion, mice were subjected to IA20%-2BC paradigm for three consecu-
tive weeks as described above. After 1 week of alcohol withdrawal, mice
received two sessions of intermittent access to 0.033% saccharin two-
bottle choice drinking paradigm. One day after the last saccharin-drinking
session, spontaneous locomotor activity was measured for 60 min in
activity monitoring chambers (43 cm×43 cm) with horizontal photo
beams (Med Associates, St Albans, VT, USA).
Data analysis
Depending on the experiment, data were analyzed using appropriate
statistical test, including two-tailed paired or unpaired t-test, two-way
analysis of variance (ANOVA) or one- or two-way repeated measures
ANOVA is detailed in the Figure Legends. Significant main effects and
interactions of the ANOVAs were further investigated with the Student–
Newman–Keuls post hoc test or method of contrast analysis. Data are
expressed as mean± s.e.m. Statistical significance was set at Po0.05.
D’Agostino–Pearson normality test and F-test/Levene test were used to
verify the normal distribution of variables and the homogeneity of
variance, respectively. The excessive drinking of alcohol animals included
for biochemical and behavioral experiments were chosen based on the
criteria described previously.36,38 No randomization method was used to
allocate animals in each group. No blinding analysis was performed for the
animal allocation. Samples were collected from each animal brain. The
exact number of samples indicates biological replicates and are indicated
in each Figure Legend. No statistical analysis was used to determine
sample size a priori. The sample sizes we chose here are similar to those
used in previous publications.13,39
RESULTS
Alcohol intake promotes the translation of CRMP-2 mRNA via
mTORC1
First, we tested whether excessive drinking of alcohol activates the
translation of selected mRNAs whose translation is mTORC1-
dependent and are involved in plasticity mechanisms. To do so,
rats underwent 8 weeks of repeated cycles of excessive alcohol
intake and withdrawal.38 This paradigm results in a binge alcohol-
drinking phenotype in which animals consume large quantities of
alcohol in a short time reaching blood alcohol concentration that
is above 80 mg%,38 which corresponds to blood alcohol
concentration values of binge drinking in humans.40 Rat NAc
was dissected immediately after the last binge-drinking session
(Timeline, Figure 1a), and polysomes that contain mRNA under-
going translation were purified (Supplementary Figure 1). As
shown in Figure 1, the mRNA levels of Arc, CaMKIIα, CRMP-2, GluA1,
Homer2 and PSD-95, but not GluN1 and RACK1, were significantly
increased in the polysomal fraction of rats that consumed alcohol
as compared with rats that drank only water (Figure 1b and
Table 1). The increase in polysomal mRNA levels of Arc, CaMKIIα,
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CRMP-2, Homer2 and PSD-95 mRNAs, but not GluA1, were still
detected after 24 h of abstinence (Supplementary Figure 2A and
Table 1). Alcohol drinking did not produce an increase in the total
RNA of any of the genes (Supplementary Figure 2B and C and
Table 1), indicating that transcriptional activation did not occur in
response to alcohol. The level of TrkB mRNA, whose translation is
not known to be controlled by mTORC1, was also unaltered by
alcohol (Figure 1b and Supplementary Figure 2).
mRNAs consisting a 5’ terminal oligopyrimidine structure are
thought to be regulated by mTORC1.41 Therefore, we used an
in silico approach (RefSeq, http://www.ncbi.nlm.nih.gov/refseq/) to
examine the transcriptional start site of the mRNAs whose
translation was activated by alcohol. Among the candidate mRNAs
listed in Figure 1b, we observed that only CRMP-2 contains a
terminal oligopyrimidine-like mRNA signature (Supplementary
Figure 3). As CRMP-2 mRNA was previously identified as a terminal
oligopyrimidine mRNA,17 we focused our studies on this gene.
First, we confirmed that CRMP-2 mRNA is increased in the
polysomal fraction in response to alcohol intake and withdrawal
by quantitative reverse transcription-PCR (Supplementary Figure 4
and Table 1). The total mRNA levels of CRMP-2 were unaltered in
response to alcohol intake, and neither were the total and
polysomal levels of RACK1 (Supplementary Figure 4). Next, to
confirm that the alcohol-mediated increase in CRMP-2 translation
is indeed mTORC1-dependent, rapamycin or vehicle was systemi-
cally administered, and polysomal RNA from rat NAc was isolated
24 h after the last alcohol-drinking session (timeline, Figure 1c). As
shown in Figure 1d, the alcohol-mediated increase in polysomal
CRMP-2 mRNA was blocked by rapamycin. In contrast, the
polysomal mRNA levels of RACK1 or total mRNA levels of CRMP-
2 and RACK1 were unaltered in the presence or absence of
rapamycin (Supplementary Figure, Table 1). Together, these
results suggest that alcohol activates the translation of CRMP-2,
Figure 1. Alcohol intake promotes the translation of CRMP-2 mRNA via mTORC1. (a) Timeline of experiment depicted in (b). (b) Rats were
subjected to IA20%-2BC-drinking procedure for 2 months. The NAc was removed at the end of the last 30 min binge alcohol-drinking session.
Control animals underwent the same paradigm but had access to water only (W). Polysomes were isolated and mRNA levels were determined
by RT-PCR analysis. The PCR products were separated on 1.5% agarose gels, photographed by Image Lab and quantified by using ImageJ. The
vertical lines indicate that the samples were from the same gel but were not run in adjacent lanes. Data are expressed as the average ratio of
each gene to GAPDH± s.e.m., and are expressed as percentage of water control. Significance was determined using two-tailed unpaired t-test.
Arc, t(6)= 2.805, P= 0.031; CaMKIIα, t(6)= 2.475, P= 0.048; CRMP-2, t(6)= 2.914, P= 0.027; GluA1, t(6)= 2.569, P= 0.042; Homer2, t(6)= 3.276,
P= 0.017; GluN1, t(6)= 1.283, P= 0.247; PSD-95, t(6)= 3.209, P= 0.018; RACK1, t(6)= 0.902, P= 0.401; TrkB, t(6)= 0.903, P= 0.401. (c) Timeline of
experiment depicted in (d). Three hours before the end of the last 24 h of alcohol withdrawal, rats were systemically administered with
10 mg kg− 1 of rapamycin or vehicle. (d) The NAc was removed 3 h after rapamycin or vehicle treatment and was subjected to polysomal RNA
fractionation. mRNA levels were measured by RT-qPCR analysis. Data are expressed as the average ratio of CRMP-2 to GAPDH± s.e.m., and
expressed as percentage of water plus vehicle. Significance was determined using two-way ANOVA and the method of contrasts. Two-way
ANOVA showed a significant main effect of alcohol (F(1,16)= 5.07, P= 0.039) and rapamycin (F(1,16)= 9.087, P= 0.008) but no interaction
(F(1,16)= 1.123, P= 0.305); and the method of contrasts detected a significant difference between water and alcohol within the vehicle group
(P= 0.048) and a significant difference between vehicle and rapamycin within the alcohol group (P= 0.029). (b) n= 4, (d) n= 5 for each group.
*Po0.05.
mTORC1-mediated translation of CRMP-2 and alcohol
F Liu et al
91
Molecular Psychiatry (2017), 89 – 101
Table 1. Individual alcohol-drinking data in rodents used for biochemical experiments
Animals drinking data
Figure 1b and Supplementary
Figure 2B
Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session (g kg− 1 24 h− 1) Binge
(g kg− 1 30 min− 1)
Animal numbers 1 6.10 0.89
N= 4 2 7.23 1.89
3 6.31 0.72
4 6.07 1.46
Mean± s.e.m. 6.43± 0.27 1.24± 0.27
Figure 1d and Supplementary
Figure 5
Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Vehicle group Rapamycin group
Animal numbers 1 4.75 4.92
N= 5 2 5.20 4.32
3 4.11 4.30
4 5.89 5.76
5 3.62 5.24
Mean± s.e.m. 4.71± 0.40 4.91± 0.28
Figures 2b and c Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Binge
(g kg− 1 30 min− 1)
Animal numbers 1 5.65 0.85
N= 10 2 7.24 1.46
3 8.56 1.16
4 5.79 1.54
5 6.65 0.83
6 4.38 0.69
7 5.60 0.68
8 5.67 1.54
9 7.43 1.52
10 5.17 1.84
Mean± s.e.m. 6.21± 0.39 1.21± 0.13
Figures 2d and e Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
( g kg− 1 24 h− 1)
Animal numbers 1 5.00
N= 10 2 4.51
3 5.58
4 6.51
5 4.59
6 7.22
7 4.45
8 3.90
9 4.70
10 3.47
Mean± s.e.m. 4.99± 0.36
Figures 3a and b Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session
( g kg− 1 24 h− 1)
Binge
(g kg− 1 30 min− 1)
Animal numbers 1 4.73 1.32
N= 6 2 4.58 1.00
3 5.67 1.54
4 7.43 1.52
5 5.17 1.84
6 4.87 1.43
Mean± s.e.m. 5.41± 0.43 1.44± 0.11
Figures 3c and d Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Binge
(g kg− 1 30 min− 1)
Animal numbers 1 4.26 0.90
N= 8 2 4.01 1.43
3 4.73 1.32
4 4.58 1.00
5 5.67 1.54
6 7.43 1.52
7 5.17 1.84
8 4.87 1.43
Mean± s.e.m. 5.09± 0.38 1.37± 0.11
mTORC1-mediated translation of CRMP-2 and alcohol
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Table 1. (Continued )
Animals drinking data
Figure 3f and Supplementary
Figure 9B
Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 3.50
N= 6 2 5.30
3 5.00
4 6.07
5 5.96
6 4.19
Mean± s.e.m. 5.00± 0.41
Figures 3h and i Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 3.07
N= 8 2 6.78
3 4.84
4 3.03
5 6.37
6 3.12
7 6.10
8 3.84
Mean± s.e.m. 4.64± 0.56
Supplementary Figure 2A
(except CRMP-2), 2C
Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 5.84
N= 4 2 6.15
3 6.93
4 6.47
Mean± s.e.m. 6.35± 0.23
Supplementary Figure 2A
CRMP-2
Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 5.28
N= 7 2 3.10
3 3.43
4 5.84
5 6.15
6 6.93
7 6.47
Mean± s.e.m. 5.23± 0.66
Supplementary Figure 4D-E Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Binge
(g kg− 1 30 min− 1)
Animal numbers 1 6.05 1.01
N= 6 2 9.69 1.40
3 3.54 0.93
4 6.10 0.89
5 7.23 1.89
6 6.31 0.72
Mean± s.e.m. 6.49± 0.81 1.14± 0.18
Supplementary Figure 4F-G Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
1 5.28
Animal numbers 2 3.10
N= 6 3 3.43
4 5.84
5 6.15
6 6.93
Mean± s.e.m. 5.12± 0.63
Supplementary Figure 6A-B Drinking paradigm
IA20%-2BC binge rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Binge
(g kg− 1 30 min− 1)
Animal numbers 1 5.65 0.85
N= 6 2 7.24 1.46
3 8.56 1.16
4 5.79 1.54
5 6.65 0.83
6 4.38 0.69
Mean± s.e.m. 6.38± 0.59 1.09± 0.14
mTORC1-mediated translation of CRMP-2 and alcohol
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Table 1. (Continued )
Animals drinking data
Supplementary Figure 6C-D Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 5.00
N= 6 2 4.51
3 5.58
4 6.51
5 4.59
6 7.22
Mean± s.e.m. 6.57± 0.45
Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 3.29
N= 4 2 7.18
3 2.16
4 3.25
Mean± s.e.m. 3.97± 1.10
Supplementary Figure 7A Drinking paradigm
IA20%-2BC 1 week-withdrawal
rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 5.20
N= 4 2 3.45
3 2.79
4 5.24
Mean± s.e.m. 4.17± 0.62
Supplementary Figure 7B-C Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 5.00
N= 3 2 4.51
3 5.58
Mean± s.e.m. 5.03± 0.31
Supplementary Figure 7D Drinking paradigm
C10%-2BC rat
Rat number Last drinking session
(g kg− 1 24 h− 1)
Animal numbers 1 2.97
N= 4 2 0.84
3 0.34
4 2.89
Mean± s.e.m. 1.76± 0.53
Supplementary Figure 8B-C Drinking paradigm
IA20%-2BC 24 h-withdrawal
mouse
Mouse Number Last drinking session
(g kg− 1 24 h− 1)
Vehicle group Rapamycin group
Animal numbers 1 11.11 10.38
N= 5 2 13.00 11.50
3 11.56 9.41
4 12.03 10.43
5 8.18 10.37
Mean± s.e.m. 11.18± 0.81 10.42± 0.33
Supplementary Figure 9C Drinking paradigm
IA20%-2BC 24 h-withdrawal rat
Rat number Last drinking session
(g kg 24 h− 1)
Animal numbers 1 3.50
N= 7 2 3.10
3 5.30
4 5.00
5 6.07
6 5.96
7 4.19
Mean± s.e.m. 4.73± 0.44
Individual alcohol drinking data in rodents used for biochemical experiments. Alcohol intake is expressed as mean± s.e.m.
mTORC1-mediated translation of CRMP-2 and alcohol
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a terminal oligopyrimidine-like mRNA, in an mTORC1-dependent
manner.
Binge drinking of 20% alcohol and acute withdrawal increase
CRMP-2 protein levels in the NAc
Next, we tested whether the alcohol-mediated increase in
polysomal CRMP-2 mRNA corresponds with an upregulation of
CRMP-2 protein. As CRMP-2 is located in both soma and synaptic
structures,33,42,43 we measured the immunoreactivity of the
protein in total homogenate as well as in crude synaptosomal
fraction of rat NAc, which were dissected either at the end of last
binge-drinking session or after 24 h of abstinence (timeline,
Figure 2a). We found that the protein levels of CRMP-2, but not
RACK1, were significantly increased in total homogenate and
synaptic fraction in response to binge drinking of alcohol
(Figures 2b and c and Supplementary Figure 6A and B, Table 1).
CRMP-2 levels remained elevated after 24 h of withdrawal
(Figures 2d and e and Supplementary Figure 6C and D, Table 1),
but returned to basal levels after 1 week of withdrawal
(Supplementary Figure 7A, Table 1). We did not detect alterations
in CRMP-2 levels in response to alcohol intake in the motor cortex
and cerebellum (Supplementary Figure 7B and C, Table 1).
Furthermore, CRMP-2 levels in the NAc were unchanged in
response to consumption of moderate amounts of 10% alcohol for
21 consecutive days (Supplementary Figure 7D, Table 1). Finally,
similarly to the results in rats, excessive alcohol drinking led to an
mTORC1-dependent increase in CRMP-2 protein levels in mouse
NAc (Supplementary Figure 8, Table 1). Together, these results
suggest that repeated cycles of binge drinking and withdrawal
promotes the translation of CRMP-2 mRNA and that the change is
specifically localized to the NAc.
Excessive drinking of alcohol blocks the phosphorylation of
CRMP-2 and increases microtubule content
CRMP-2 is a substrate of glycogen synthase kinase-3β (GSK-3β).43
GSK-3β activity is regulated by the serine and threonine kinase
AKT.44 Specifically, AKT phosphorylates GSK-3β at Serine 9, which
in turn inactivates the kinase.44 Excessive alcohol intake activates
AKT in the NAc of rodents.45 Therefore, we hypothesized that the
consequences of alcohol-mediated AKT activation are increased
phosphorylation of GSK-3β and a subsequent blockade of CRMP-2
phosphorylation at Threonine 514, a site that is specifically targeted
by GSK-3β.43 As shown in Figures 3a and b, the phosphorylation of
GSK-3β was significantly elevated in rat NAc after binge drinking of
alcohol; and importantly, CRMP-2 phosphorylation was significantly
decreased in total homogenate and in synaptic fraction after a
session of excessive alcohol intake (Figures 3c and d, Table 1) and
withdrawal (Supplementary Figure 9, Table 1).
Phosphorylation of CRMP-2 inhibits its binding to micro-
tubules.27,46 Therefore, we tested whether excessive alcohol
consumption alters the binding of CRMP-2 to microtubules. To
do so, rat NAc was harvested 24 h after the last drinking session,
total homogenates were incubated with pre-assembled micro-
tubules, and microtubules-associated proteins were isolated. As
shown in Figures 3e and f, alcohol drinking significantly increased
the immunoreactivity of CRMP-2 in the microtubules-enriched
Figure 2. Binge drinking of alcohol and withdrawal increase CRMP-2 protein levels. (a) Timeline of experiment depicted in (b–e). The NAc was
removed 30 min after the beginning (b and c, binge, B) or 24 h after the end of the last drinking session (d–e, withdrawal). Protein levels were
determined by western blot analysis. ImageJ was used for optical density quantification. Data are expressed as the average ratio± s.e.m. of
CRMP-2 or RACK1 to GAPDH, and are expressed as percentage of water (W) control. Significance was determined using two-tailed unpaired
t-test. (b) Protein levels in the total homogenate of binge-drinking rats. CRMP-2, t(18)= 2.537, P= 0.02. (c) Protein levels in the synaptic fraction
of binge drinking rats. CRMP-2, t(18)= 3.596, P= 0.002. (d) Protein levels in the total homogenate 24 h after withdrawal. CRMP-2, t(18)= 4.182,
Po0.001. (e) Protein levels in the synaptic fraction 24 h after withdrawal. CRMP-2, t(18)= 4.887, Po0.001. n= 10 for each group. *Po0.05,
**Po0.01, ***Po0.001.
mTORC1-mediated translation of CRMP-2 and alcohol
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Figure 3. Binge drinking of alcohol blocks the phosphorylation of CRMP-2 and increases microtubule content. (a–i) Rats were trained to drink
alcohol as described in Figures 1a. (a–d) The NAc was removed 30 min after the beginning of the last drinking session (binge, B).
Phosphorylation of GSK-3β and CRMP-2 was determined by western blot analysis. Quantification was conducted as in Figure 2. The vertical
lines indicate that separates groups were from the same gel but were not run in adjacent lines. Data are expressed as the average ratio of
phospho-GSK-3β to total GSK-3β or phospho-CRMP-2 to total CRMP-2± s.e.m., and are expressed as percentage of water (W) control.
Significance was determined using two-tailed unpaired t-test. (a) [S9]GSK-3β phosphorylation in total homogenate, t(10)= 3.141, P= 0.011. (b)
[S9]GSK-3β phosphorylation in the synaptic fraction, t(10)= 3.574, P= 0.005. (c) [T514]CRMP-2 phosphorylation in total homogenate, t(14)= 3.119,
P= 0.008. (d) [T514]CRMP-2 phosphorylation in the synaptic fraction, t(14)= 3.18, P= 0.007. (e–i) The NAc were removed 24 h after the end of
the last drinking session (withdrawal). (e and f) Microtubule-binding assay. (e) CRMP-2 and tubulin levels in the pellet fraction were
determined by western blot analysis. (f) Optical density quantification of Microtubules-bound CRMP-2 is expressed as the ratio of CRMP-2
(pellet) to tubulin (pellet)± s.e.m. t(11)= 2.271, P= 0.044. (g–i) Microtubule content assay. Tubulin and GAPDH levels in fraction were detected
by western blot analysis. Optical density quantification of the microtubule content (h) and total tubulin (i) are expressed as the ratio of tubulin
(pellet) to tubulin (supernatant)± s.e.m. t(14)= 2.42, P= 0.029, and tubulin (total) to GAPDH (total), t(14)= 1.207, P= 0.248, respectively.
(j) Diagram of the proposed signaling cascade. Excessive drinking of alcohol leads to newly synthesized CRMP-2 in a hypophosphorylated
state through the activation of mTORC1 and the inhibition of GSK-3β that in turn promotes microtubule assembly. (a, b) n= 6, (c–d, h–i) n= 8
for each group; (f) n= 7 water, n= 6 withdrawal. *Po0.05, **Po0.01.
mTORC1-mediated translation of CRMP-2 and alcohol
F Liu et al
96
Molecular Psychiatry (2017), 89 – 101
pellet fraction, indicating that CRMP-2 binding to microtubules is
increased in response to alcohol intake. CRMP-2 promotes
microtubule assembly after binding to microtubules.27 Therefore,
we tested whether excessive alcohol intake increases microtubule
content by promoting its assembly. As shown in Figures 3g and h,
alcohol significantly increased the ratio of microtubules-associated
tubulin to free tubulin. In contrast, the levels of total tubulin were
unaltered by alcohol (Figures 3g and i, Table 1). Together, these
findings suggest that excessive alcohol drinking blocks the
phosphorylation of CRMP-2 and promotes newly synthesized,
hypophosphorylated, CRMP-2 binding to microtubules, resulting
in microtubule assembly (Figure 3j).
Systemic administration of the CRMP-2 inhibitor lacosamide
decreases binge drinking of alcohol in rodents
Microtubules maintain the morphology of neurons and have an
important role in structural plasticity.47,48 Structural plasticity,
which involves the formation, stabilization and elimination of
synapses,49 is linked to compulsive drug taking and seeking.50 We
therefore hypothesized that CRMP-2-mediated microtubule
assembly participates in the development and/or maintenance
of excessive alcohol-drinking behaviors. We utilized the CRMP-2
inhibitor, lacosamide, which binds with CRMP-2 and inhibits
CRMP-2-induced microtubule assembly and neurite growth,51,52
and tested whether lacosamide reduces excessive alcohol
Figure 4. Systemic administration of the CRMP-2 inhibitor lacosamide decreases binge drinking of alcohol in rodents. (a) Timeline of
experiments depicted in (b–f). (b) Rats were subjected to IA20%-2BC for 2 months. Vehicle (Veh) or lacosamide (LCM, 20 mg kg− 1) was
systemically administered 90 min before the beginning of a drinking session. Alcohol intake was measured 30 min after the beginning of a
drinking session. Data are presented as mean± s.e.m. Significance was determined using two-tailed paired t-test, t(8)= 4.176, P= 0.003. (c) Rats
were subjected to an intermittent access to sucrose solution two-bottle choice drinking procedure for 2 weeks. Vehicle (Veh) or lacosamide
(LCM, 20 mg kg− 1) was systemically administered 90 min before the beginning of a drinking session. Sucrose intake was measured 30 min
after the beginning of a drinking session. Data are presented as mean± s.e.m. Significance was determined using two-tailed paired
t-test, t(9)=− 0.059, P= 0.954. (d–f) Mice experienced 2 months of IA20%-2BC-drinking paradigm. Vehicle (Veh) or lacosamide (LCM, 20 or
50 mg kg− 1) were systemically administered 90 min before the beginning of a drinking session. Alcohol intake (d), alcohol preference (e) and
water intake (f) were measured at the end of a 4 h drinking session. Data are presented as mean± s.e.m. Significance was determined using
one-way RM-ANOVA and post hoc Student–Newman–Keuls test. (d) Alcohol intake. One-way RM-ANOVA showed a significant main effect of
lacosamide (F(2,20)= 9.842, P = 0.001), and post hoc Student–Newman–Keuls test, q= 6.081, P= 0.001. (e) Alcohol preference is expressed as the
ratio of alcohol intake to total fluid intake. One-way RM-ANOVA showed a significant main effect of lacosamide (F(2,20)= 8.715, P= 0.002), and
post hoc Student–Newman–Keuls test, q= 5.453, P= 0.003. (f) Water intake. One-way RM-ANOVA showed a significant main effect of
lacosamide (F(2,20)= 4.029, P= 0.034), and post hoc Student–Newman–Keuls test, q= 3.627, P= 0.047. (b) n= 9, (c) n= 10, (d–f) n= 11 for each
group. *Po0.05, **Po0.01, ***Po0.001.
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consumption in rodents (timeline, Figure 4a). As shown in
Figure 4b (rats) and 4D-F (mice), systemic administration of
lacosamide significantly decreased binge drinking of alcohol,
alcohol preference, but did not reduce the consumption of water.
Systemic administration of lacosamide did not affect rat sucrose
consumption (Figure 4c), suggesting that the drug does not alter
general reward. In addition, to rule out putative locomotor or
anxiolytic effects of lacosamide,53 we tested the effect of the drug
on spontaneous locomotion and basal anxiety-like behavior
(Supplementary Figure 10). Vehicle and lacosamide-treated rats
did not exhibit significant differences in distance traveled
(Supplementary Figure 10) or time spent in the center of the
chamber (Supplementary Figure 10). Together, these results
indicate that lacosamide decreases binge drinking of alcohol in
rodents without affecting the general reward system, basal
locomotor activity or anxiety levels.
Knockdown of CRMP-2 in the mouse NAc decreases excessive
drinking of alcohol
To test the specific contribution of CRMP-2 in the NAc to
alcohol drinking, we generated a lentivirus expressing a short
hairpin RNA targeting the CRMP-2 gene (Ltv-shCRMP-2), and
Figure 5. Knockdown of CRMP-2 in the mouse NAc decreases excessive drinking of alcohol. (a–e) A lentivirus expressing non-specific control
shRNA (Ltv-shCT) (2 × 107 pg ml− 1) or shRNA-targeting mouse CRMP-2 (Ltv-shCRMP-2) (2 × 107 pg ml− 1) was infused bilaterally into the
mouse NAc (1.2 μl per side). After 3 weeks of recovery, mice underwent IA20%-2BC drinking procedure for eight sessions. The NAc was
dissected at the end of behavioral experiment and used for immunohistochemistry (a) and western blot analysis (b). (a) Ltv-shCRMP-2 infects
NAc neurons. Slices were stained with anti-GFP antibodies. Left panel (×5) depicts the specificity of the site of virus infection. Scale bar,
500 μm. Middle image (×40) depicts Ltv-shCRMP-2 infection of neurons. Scale bar, 25 μm. Right panel (×63) shows a representative neurite
from an infected neuron. Scale bar, 5 μm. (b) Ltv-shCRMP-2 infection decreases CRMP-2 expression in the NAc. Left, the protein levels of
CRMP-2, tubulin, RACK1 and GAPDH were determined by western blot analysis. Right, histogram depicts the ratio of CRMP-2 to GAPDH levels.
Significance was determined using two-tailed unpaired t-test, t(6)= 6.414, P= 0.0007. (c) Timeline of experiments depicted in (d) and (e).
Alcohol intake (d) and alcohol preference (e) were measured after each 24 h drinking session and expressed as an average of every two
drinking sessions. (d) Alcohol intake. Two-way RM-ANOVA showed a significant main effect of virus infusion (F(1,20)= 6.883, P= 0.016), a
significant effect of session (F(3,60)= 51.502, Po0.001) and no interaction between virus infusion and session (F(3,60)= 1.969, P= 0.128). (e)
Alcohol preference is expressed as the ratio of alcohol intake to total fluid intake. Two-way RM-ANOVA showed a significant main effect of
virus infusion (F(1,20)= 8.585, P= 0.008), a significant effect of session (F(3,60)= 29.666, Po0.001) and no interaction between virus infusion and
session (F(3,60)= 1.344, P= 0.269). *Po0.05, **Po0.01, ***Po0.001. (b) n= 4, (d and e) n= 11 for each group.
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tested whether knockdown of the gene reduces alcohol intake.
Infection of Ltv-shCRMP-2 in mouse NAc (Figure 5a) led to a
significant decrease in CRMP-2 protein level but not in the
immunoreactivity of tubulin, RACK1 or GAPDH (Figure 5b and
Supplementary Figure 11A). Furthermore, the knockdown of
CRMP-2 was restricted to the NAc, as no change in CRMP-2
protein level was observed in the neighboring dorsal striatum
(Supplementary Figure 11B).
Next, we measured the levels of voluntary alcohol intake of
mice infected with Ltv-shCRMP-2 or a lentivirus expressing a non-
specific short hairpin control sequence (Ltv-shCT) (Timeline,
Figure 5c). We found that knockdown of CRMP-2 in the NAc
resulted in a significant decrease in excessive alcohol intake
(Figure 5d) and preference (Figure 5e) as compared with Ltv-shCT-
infected mice. Water intake was increased after knockdown of
CRMP-2 in the NAc, which is likely a countervailing effect
(Supplementary Figure 12A). Knockdown of CRMP-2 in mouse
NAc did not change the consumption of another rewarding
substance, saccharin (Supplementary Figure 12B), and locomotor
activity was also unaltered (Supplementary Figure 12C). Together,
these results indicate that CRMP-2 in the NAc has an important
role in the development of excessive alcohol drinking without
altering the general reward system or spontaneous locomotor
activity.
DISCUSSION
Here, we show that excessive consumption of alcohol results in
the induction of specific mTORC1-dependent mRNA translation in
the NAc. One of the identified mRNAs whose translation is
triggered by alcohol is the microtubule-binding protein, CRMP-2.
We further present data to suggest that the alcohol-mediated
inhibition of GSK-3β leads to an increase in CRMP-2 in its
hypophosphorylated form. Thus, mTORC1 activation and GSK-3β
inhibition in the NAc converge on CRMP-2 resulting in its
association with microtubules, which in turn increases micro-
tubule content (Supplementary Figure 13). Importantly, pharma-
cologic inhibition of CRMP-2 function or specific knockdown of
CRMP-2 levels in the NAc attenuates excessive alcohol drinking,
suggesting that CRMP-2 is an important contributor to neuroa-
daptations underlying excessive drinking behaviors.
De novo protein synthesis is crucial for the molecular mechan-
isms underlying long-lasting neuroadaptations in response to
drugs of abuse,3,54 including alcohol.11 Here, we demonstrate that
excessive drinking of alcohol activates the translation of several
mTORC1-dependent candidate mRNAs in the NAc of rats, all of
which contribute to synaptic functions. Several of these mTORC1-
dependent effectors have been previously linked to various
alcohol-related actions. Specifically, Pandey et al.55 reported that
Arc in the amygdala controls alcohol intake in rats; and we
previously found that Arc mRNA to protein translation is induced
in amygdala and cortical regions by retrieval of alcohol-associated
memories.14 Furthermore, the immunoreactivity of GluA1 is
increased in the NAc of rodents in response to excessive drinking
of alcohol,13 and AMPAR in the dorsomedial striatum has a role in
alcohol seeking and drinking.56 In addition, Easton et al.57 recently
reported that CaMKIIα autophosphorylation-deficient mice show
reduced alcohol preference compared with wild-type mice.
Homer2 protein levels in the NAc have also been shown to be
induced by alcohol and to contribute to excessive alcohol
consumption.58 Furthermore, PSD-95 knockout mice exhibit
hypersensitivity to alcohol intoxication and show decreased
voluntary alcohol intake.59 Our findings therefore put
forward the possibility that mTORC1, by simultaneously inducing
the translation of a group of synaptic proteins, is a molecular
gateway responsible for neuroadaptations induced by alcohol
drinking.
We found that the increase in polysomal mRNA of Arc, CaMKIIα,
CRMP-2, Homer2 and PSD-95 was still maintained after 24 h of
alcohol withdrawal. These results are in accordance with our
previous findings showing that the activation of mTORC1 is still
detected in rodents’ NAc after 24 h of alcohol withdrawal.13 These
findings raise the possibility that the initiation of alcohol-induced
mTORC-1-dependent mRNA translation is not directly related to
the pharmacological effects of alcohol, but rather are stable
changes that depend on the previous history of alcohol exposure
and are components of the neuroadaptations that persist through
a short withdrawal period. We further observed that CRMP-2 levels
returned to baseline levels after 1 week of withdrawal. It is
plausible that downstream effectors of CRMP-2 are participating in
the neuroadaptations that are observed during prolonged period
of abstinence from alcohol drinking. Importantly, the increase in
CRMP-2 levels were dependent on the concentration of alcohol as
the increases were detected in response to a history of drinking of
intermittent access to 20% alcohol, a paradigm that mimics
excessive drinking of alcohol in humans,38 but not after
continuous access to 10% alcohol that results in moderate levels
of drinking. These results are likely to reflect the notion that the
mechanisms underlying moderate and excessive drinking of
alcohol are different.60 Finally, alcohol-mediated increase in
CRMP-2 expression is brain region specific as CRMP-2 levels were
elevated in the NAc but not in the motor cortex or cerebellum,
possibly because both regions are not directly related to the
reward pathway.
CRMP-2 is a substrate of GSK-3β,43 which is a direct downstream
substrate of AKT44 (Supplementary Figure 13). Phosphorylation of
GSK-3β inhibits its enzymatic activity44 and we show GSK-3β is
phosphorylated by AKT after binge drinking of alcohol (as shown
herein) and withdrawal.45 We found that in the NAc, basal levels of
GSK-3β phosphorylation are low, suggesting that GSK-3β is
constitutively active. In contrast, CRMP-2 phosphorylation is high
in the NAc of water-consuming animals, indicating that constitu-
tively active GSK-3β phosphorylates CRMP-2. Importantly, alcohol-
mediated GSK-3β phosphorylation (and thus inhibition) is
paralleled with a significant reduction in CRMP-2 phosphorylation
suggesting that alcohol-mediated inhibition of this kinase has
positive biological consequences. It is important to note however
that the decrease in CRMP-2 phosphorylation by alcohol may also
require the activity of a phosphatase. One possible candidate is
protein phosphatase 2A, which was reported to dephosphorylate
CRMP-2 at Threonine 514.61 Another potential candidate is protein
phosphatase 1, which dephosphorylates CRMP-2 at Threonine 514
when GSK-3β activity is inhibited.62 Further research is required to
test the potential role of phosphatases in CRMP-2 function in
response to alcohol.
Microtubule dynamics in dendritic spines is a critical compo-
nent of structural plasticity.48 CRMP-2 is a microtubules-associated
protein that stabilizes microtubules and promotes neurite
outgrowth,27,63 which further provides the basis for neuronal
morphology and structural plasticity.48,64,65 Our results suggest
that the functional consequences of alcohol-mediated increases
in CRMP-2 protein levels and the blockade of CRMP-2 phosphor-
ylation is the enhanced binding of CRMP-2 to microtubules,
leading to the enhancement of microtubule assembly. Thus, our
results raise the possibility that alcohol intake changes neuronal
morphology through CRMP-2-dependent microtubule dynamics,
which underlie the development and maintenance of alcohol-
drinking behaviors. In support of this possibility, we show that
knockdown of CRMP-2 in the NAc results in a robust decrease in
excessive alcohol intake and preference, suggesting that CRMP-2
in the NAc is a molecular gateway to control alcohol-drinking
behaviors. The relationship between alcohol exposure and
structural plasticity in the striatum has been recently reported.
Specifically, DePoy et al.66 showed that chronic intermittent
alcohol vapor exposure results in neuronal dendritic hypertrophy
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in the dorsolateral striatum, and we recently found that excessive
drinking of alcohol leads to changes in dendrite morphology
in dopamine D1 receptor neurons in the dorsomedial striatum
of mice.67 It would therefore be of interest to determine
whether CRMP-2-mediated changes in microtubule content
contribute to these or others synaptic morphology changes
induced by alcohol.
Finally, we demonstrate that systemic administration of
lacosamide decreases binge drinking of alcohol in both rats and
mice and that this effect is not generalized to other rewarding
substances. Lacosamide interacts with CRMP-2 and inhibit
CRMP-2-induced microtubule assembly as well as neurite
growth.51,52 However, lacosamide has also been shown to increase
slow inactivation of voltage-gated sodium channels.68 Thus, we
cannot rule out the possibility that lacosamide decreases
excessive drinking of alcohol, at least in part, through other
mechanisms. Unfortunately, we could not examine alcohol
induction of microtubule assembly after knockdown of CRMP-2
or lacosamide administration, as we could not differentiate
between changes in microtubule assembly that are due to the
treatment per se or that are due to the reduction in alcohol intake.
Nevertheless, lacosamide, an FDA-approved drug used for the
treatment of seizures.69 Thus, this drug and possibly other
CRMP-2-microtuble inhibitors represent a promising strategy for
the treatment of alcohol-related disorders.
The raw data can be found at https://portal.g-node.org/data/.
Readers can access the data by creating an account and searching
for “Liu”.
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